Side-by-side comparison of AI visibility scores, market position, and capabilities
Most cited AI agent framework in 2026; LangGraph has 8,200+ GitHub stars. $25M Series A at $200M valuation. LangSmith observability platform for production agents. Used in majority of enterprise multi-agent deployments; 80K+ GitHub stars total.
LangChain was founded in 2022 by Harrison Chase and emerged from the open-source community as the dominant framework for building applications powered by large language models. Originally a Python library, it provided developers with composable building blocks—chains, agents, memory modules, and tool integrations—to connect LLMs with external data sources and APIs. The framework addressed a critical gap: making it practical to build production-grade LLM applications beyond simple prompt-and-response patterns.\n\nLangChain's product portfolio has expanded significantly, with LangGraph serving as its graph-based orchestration layer for stateful, multi-actor AI agent workflows. LangSmith provides observability, debugging, and evaluation tooling for LLM pipelines in production. The commercial LangChain Platform offers hosted deployment and collaboration features for enterprise teams. These products target AI engineers, ML teams at enterprises, and the broader developer community building agent-based systems and RAG pipelines.\n\nWith over 100,000 active developers and LangGraph accumulating 8,200+ GitHub stars, LangChain remains the most cited AI agent framework heading into 2026. The company raised a $25M Series A at a $200M valuation and has become deeply embedded in how enterprises build and deploy AI agents. Its ecosystem of integrations—covering hundreds of LLM providers, vector databases, and tools—makes it a foundational layer of the modern AI application stack.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.